1
|
Ilhao Moreira R, Cambronero Cortinas E, Giannakopoulos G, Wong CY, Maria Joao Vieira MJV, Neves Pestana G, Andjelkovic K, Pavon AG, Nunes A, Portero Portaz JJ, Stefan C, Namitokov A, Chivulescu M, Wojtkowska A, Gomes AC, Jurko T, Cazzoli I, Valente F, Moura Branco L, Coutinho Cruz M, Pinto Teixeira P, Almeida Morais L, Viveiros Monteiro A, Oliveira M, Ramos R, Agapito A, Cruz Ferreira R, Racugno P, Escribano D, Mendez J, Paya A, Bonanad C, Valle Munoz A, Corbi Pascual MJ, Chorro FJ, Bodi V, Mueller H, Catia Costa CC, Beatriz Saldanha Santos BSS, Kevin Domingues KD, Nuno Craveiro NC, Maria Luz Pitta MLP, Miguel Alves MA, Margarida Leal ML, Bernardo-Almeida P, Sousa C, Tavares-Silva M, Almeida R, Lima R, Amorim MJ, Almeida J, Macedo F, Maciel MJ, Kalimanovska Ostric D, Boricic Kostic M, Petrovic O, Petrovic M, Vujisic Tesic B, Mikic A, Kalangos A, Marini C, Rosa I, Stella S, Ancona F, Spartera M, Margonato A, Colombo A, Agricola E, Nascimento H, Maia Araujo P, Ferreira A, Pinho T, Andre Rodrigues R, Bernardo Almeida P, Campelo M, Dias P, Julia Maciel M, Tercero Martinez A, Corbi Pascual MJ, Prieto Mateos D, Urraca Espejel C, Calero Nunez S, Fuentes Manso R, Gallego Page JC, Garcia Lopez JC, Barambio Ruiz MJ, Iancovici S, Ianovici E, Zamfir D, Dorobantu M, Kizhvatova N, Kolodina M, Skaletsky K, Soroka N, Mayngart S, Kosmacheva E, Barbukhatti K, Porhanov V, Jurcut C, Enache R, Popescu BA, Ginghina C, Spirito P, Jurcut R, Tomaszewski A, Czekajska-Chehab E, Tomaszewski M, Stettner D, Wysokinski A, Fazendas P, Carvalho J, Ferreira F, Sousa L, Fiarresga A, Martins JD, Pereira H, Jurko A, Krsiakova J, Jurko AJR, Matasova K, Zibolen M, Babu-Narayan S, Senior R, Gatzoulis MA, Li W, Maldonado G, Cuellar H, Marti G, Roque A, Teixido G, Gonzalez-Alujas MT, Garcia-Dorado D, Evangelista A, Rodriguez-Palomares JF. Clinical Case Poster session 4P1046An unexpected findingP1047Coronary artery ectasia in the setting of subacute Inferior STEMIP1048Diagnosis through the back door: the utility of the subscapular acoustic windowP1049A challenging case of paravalvular leakage closureP1050A life-threatning asymptomatic incidental findingP1051Acute heart failure due to intermittent aortic prosthesis regurgitation - case reportP1052Role of echocardiography in a patient with sequels after surgical treatment of infective endocarditis on a bicuspid aortic valveP1053MitraClip to treat systolic anterior motion-induced outflow tract obstruction in hypertrophic obstructive cardiomyopathyP1054Acute heart failure by parvovirus B19P1055Multimodality assessment of myocardial involvement in female carriers of the Duchenne diseaseP1056Cardiovascular complications in hypereosinophilic syndrom-a case reportP1057Giant false left ventricle aneurysm in the myocardial infarction outcomeP1058From syncope to the diagnosis of systemic disease: the importance of a high index of suspicionP1059A total anomalous pulmonary venous return in 60-year-old patientP1060Atrial septal defect occluder fracture - diagnostic challenge in asymptomatic patientP1061Marfan syndrome in two newborn infantsP1062Isolated pulmonary valve regurgitation as a cause of severe right heart dilatation in an adult patientP1063Multimodality imaging - how to find the missing leak. Eur Heart J Cardiovasc Imaging 2016. [DOI: 10.1093/ehjci/jew261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
2
|
Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J. Endoscopic surveillance in patients with multiple (10-100) colorectal polyps. Endoscopy 2016; 48:56-61. [PMID: 26165738 DOI: 10.1055/s-0034-1392515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Abstract
BACKGROUND AND STUDY AIMS Endoscopic surveillance in patients with multiple colorectal polyps aims to reduce colorectal cancer (CRC) incidence and mortality, as well as the need for colorectal surgery. The aim of this study was to determine the risk of developing CRC or the need for surgery during endoscopic surveillance in a cohort of patients with multiple (10 - 100) colorectal polyps. PATIENTS AND METHODS This was a multicentrer, longitudinal, observational study in 15 CRC high risk clinics in Spain, carried out between January 2009 and December 2010. Patients who were included in the EPIPOLIP trial and had at least 1 year of follow-up were included in the study. The primary outcome of interest was the incidence of CRC at least 1 year following the initial colonoscopy. The secondary outcome was the need for colorectal surgery. RESULTS A total of 265 patients were followed for a median of 3.8 years. Patients underwent a median of 5 colonoscopies, and 17 patients (6.4 %) were diagnosed with CRC. A total of 32 patients (12.1 %) underwent surgery, including 15 (5.7 %) for prophylaxis without a diagnosis of CRC. The corresponding incidence density rates for CRC and colorectal surgery were 1.4 (95 % confidence interval [CI] 0.7 to 2.1) and 2.7 (95 %CI 1.7 to 3.6) per 100 patient-years, respectively. Only the presence of symptoms at first colonoscopy was independently associated with CRC diagnosis (hazard ratio [HR] 7.7, 95 %CI 1.1 to 59.3) and colorectal surgery (HR 4.6, 95 %CI 1.02 to 20.6). CONCLUSIONS Patients with more than 10 neoplastic polyps required frequent colonoscopies within a short follow-up period. More than 10 % of patients required colorectal surgery within 4 years, more than half for incident CRC.
Collapse
Affiliation(s)
- Fátima Valentín
- Department of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain
| | - Carla Guarinos
- Unidad de Investigación, Hospital General Universitario de Alicante, Alicante, Spain
| | - Miriam Juárez
- Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain
| | - María Rodríguez-Soler
- Unidad de Investigación, Hospital General Universitario de Alicante, Alicante, Spain
| | | | | | - David Nicolas-Perez
- Department of Gastroenterology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
| | - Luis Bujanda
- Department of Gastroenterology, Donostia Hospital/Biodonostia Institute, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Basque Country (UPV/EHU), San Sebastián, Spain
| | - Maite Herraiz
- Department of Gastroenterology, Clínica Universitaria de Navarra, Pamplona, Spain
| | - Luisa De-Castro
- Department of Gastroenterology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | | | - Alberto Herreros-de-Tejada
- Department of Gastroenterology, IDIPHIM, Hospital Universitario Puerta De Hierro, Majadahonda, Madrid, Spain
| | - Fernando Martínez
- Department of Gastroenterology, Instituto Valenciano de Oncología, Valencia, Spain
| | - Elena Aguirre
- Department of Oncology, Hospital Arnau de Vilanova, Lleida, Spain
| | - Ángel Ferrández
- Servicio de Aparato Digestivo, Hospital Clínico Universitario, IIS Aragón, University of Zaragoza, CIBERehd, Zaragoza, Spain
| | - José Díaz-Tasende
- Department of Gastroenterology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Virginia Piñol
- Department of Gastroenterology, Hospital Josep Trueta, Girona, Spain
| | - Artemio Paya
- Department of Pathology, Hospital General Universitario de Alicante, Alicante, Spain
| | - Cecilia Egoavil
- Department of Pathology, Hospital General Universitario de Alicante, Alicante, Spain
| | - Cristina Alenda
- Department of Pathology, Hospital General Universitario de Alicante, Alicante, Spain
| | - Antoni Castells
- Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), IDIBAPS, University of Barcelona, Barcelona, Spain
| | - Rodrigo Jover
- Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain
| | - Joaquín Cubiella
- Department of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain
| |
Collapse
|
4
|
Bessa X, Alenda C, Paya A, Álvarez C, Iglesias M, Seoane A, Dedeu JM, Abulí A, Ilzarbe L, Navarro G, Pellise M, Balaguer F, Castellvi-Bel S, LLor X, Castells A, Jover R, Andreu M. Validation Microsatellite Path Score in a Population-Based Cohort of Patients With Colorectal Cancer. J Clin Oncol 2011; 29:3374-80. [DOI: 10.1200/jco.2010.34.3947] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Purpose Bethesda guidelines are used to recognize patients at risk for Lynch syndrome. However, obtaining personal and familial tumor data can sometimes be difficult. The Microsatellite Path Score (MsPath), a pathological score, based on age, tumor location, and pathologic features, has been developed to effectively predict colorectal cancer with DNA mismatch repair (MMR) deficiencies. However, the MsPath model's performance in an unselected, population-based colorectal cancer (CRC) population is unknown. Patients and Methods We analyzed all patients with CRC regardless of age, personal or family history, and tumor characteristics from the EPICOLON study, an independent, prospective, multicenter, population-based cohort (N = 1,222). All patients underwent tumor microsatellite instability (MSI) analysis and immunostaining for MLH1/MSH2, and those with MMR underwent tumor BRAF mutation analysis and MLH1/MSH2 germline testing. All the pathologic features were centralized and evaluated blinded to the MMR status. Results MsPath score for prediction of having MSI high, with the recommended MsPath cutoff score ≥1.0, had a sensitivity, specificity, and positive predictive value (PPV) of 92.8% (95% CI, 86.9 to 98.3), 64.1% (95% CI, 61.1 to 66.8), and 15.8% (95% CI, 12.2 to 18.6), respectively. MsPath score had a sensitivity, specificity, and PPV of 81.8% (95% CI, 59.0 to 99.8), 60.6% (95% CI, 57.8 to 63.4), and 1.9% (95% CI, 0.7 to 3.1), respectively, for the identification of MLH1/MSH2 gene carriers. Application of the MsPath score, resulted in two (18%) of 11 mutation carriers being missed, both pathogenic germline MSH2 mutations. Conclusion In the general nonselected population, the MsPath score accurately predicted the probability of bearing a MSI high CRC, but it was insufficiently accurate to use for the selection of patients warranting MLH1/MSH2 mutation testing in the setting of Lynch syndrome.
Collapse
Affiliation(s)
- Xavier Bessa
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Cristina Alenda
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Artemio Paya
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Cristina Álvarez
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Mar Iglesias
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Agustín Seoane
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Josep Maria Dedeu
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Anna Abulí
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Lucas Ilzarbe
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Gemma Navarro
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Maria Pellise
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Francesc Balaguer
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Sergi Castellvi-Bel
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Xavier LLor
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Antoni Castells
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Rodrigo Jover
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| | - Montserrat Andreu
- Xavier Bessa, Cristina Álvarez, Mar Iglesias, Agustín Seoane, Josep Maria Dedeu, Anna Abulí, Lucas Ilzarbe, Gemma Navarro, Montserrat Andreu, Hospital del Mar, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Pompeu Fabra and Autonoma University; Maria Pellise, Francesc Balaguer, Sergi Castellvi-Bel, Antoni Castells, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Catalonia; Cristina Alenda, Artemio Paya, Rodrigo Jover,
| |
Collapse
|